Identification of the IFN-γ/IL-4 ratio as a prognostic biomarker and development of an immune-related prognostic model in diffuse large B-cell lymphoma
IFN-γ/IL-4 ratio is a practical prognostic marker in newly diagnosed DLBCL, and the IRPS model shows potential for predicting PFS and OS in DLBCL, enabling improved risk stratification.
Authors
- Zunmin Zhu (ORCID: https://orcid.org/0000-0002-6635-7454)
- Yuwei Zhou (ORCID: https://orcid.org/0000-0002-0379-4905)
- Chao Liu (ORCID: https://orcid.org/0000-0003-4168-1052)
- Yuqing Chen (ORCID: https://orcid.org/0009-0004-7166-8144)
- Rongjun Ma
- Pan Zhou (ORCID: https://orcid.org/0000-0002-7105-6808)
- Xiaoli Yuan (ORCID: https://orcid.org/0000-0003-0244-6674)
- Suqiong Zuo
- Xiaohang Pei
- Yang Liu (ORCID: https://orcid.org/0000-0002-1053-8205)
Institutions
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1186/s12885-025-14737-1
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- National Natural Science Foundation of China